[1] 秦可,许明雷,张辉,等.心血管外科手术中“无输血手术”的实施[J].中西医结合心血管病电子杂志,2020,8(20):43. [2] LU L Y,CHE J,CHENG W P,et al.A retrospective study of the relationship between blood transfusion and 30-day postoperative outcomes in patients undergoing isolated off-pump coronary artery bypass grafting[J].Braz J Cardiovasc Surg,2022,37(5):663-673. [3] WANG L,WANG Z X,HUANG Y G,et al.Expanding restrictive transfusion evidence in surgical practice:a multicentre,prospective cohort study[J].Blood Transfus,2022,20(5):382-394. [4] VLAAR A P,OCZKOWSKI S,DE BRUIN S,et al.Transfusion strategies in non-bleeding critically ill adults:a clinical practice guideline from the European Society of Intensive Care Medicine[J].Intensive Care Med,2020,46(4):673-696. [5] 大量输血现状调研协作组,杨江存,徐永刚,等.全国多中心大量输血凝血指标调研分析[J].中国输血杂志,2012,25(7):632-635. [6] BISHT A,MARWAHA N,KAUR R,et al.Haemovigilance Programme of India:comparative analysis of transfusion reactions reported over a 5-year period through two reporting formats and key recommendations for blood safety[J].Asian J Transfus Sci,2020,14(2):103-116. [7] 褚晓凌,郭永建.国际输血协会《非感染性输血不良反应监测标准》之解读[J].中国输血杂志,2012,25(8):812-814. [8] 黄宇光、刘忠.中国输血不良反应报告(2018-2020年)[M].北京:人民卫生出版社,2021:41-43. [9] 贺英,李金翌,邹昆,等.某医院2013年~2019年储存悬浮少白细胞红细胞临床使用及不良反应情况调查[J].湖南师范大学学报(医学版),2020,17(5):47-50. [10] 周雪莹,欧阳旭,郑伟.心脏移植患者围术期输血情况及大量输注红细胞影响因素分析[J].中国输血杂志,2022,35(8):824-828. [11] 中华人民共和国国家卫生健康委员会.输血反应分类[S].2018. [12] PACHECO L D,SAADE G R,COSTANTINE M M,et al.An update on the use of massive transfusion protocols in obstetrics[J].Am J Obstet Gynecol,2016,214(3):340-344. [14] 中华人民共和国国家卫生健康委员会.围手术期患者血液管理指南[S].2022. |